Given that MEK/ERK pathway plays a crucial role in the survival, development, gemcitabine resistance and ERRα-promoted progression of PC 10, 36, 37, we explored whether it is involved in the effectiveness of gemcitabine and XCT790 in PC. Here, ESRRA is linked to pachyonychia congenita.